On February 16, 2024, the Alabama Supreme Court issued a decision in LePage v. Center for Reproductive Medicine. The court determined that the term “minor child” in Alabama’s Wrongful Death of a Minor Act includes unborn children outside the womb (extrauterine children) in addition to unborn children inside the womb (in utero children) and born minor children. The extrauterine children whose deaths led to the wrongful death lawsuits in LePage were created through the process of in vitro fertilization (IVF), and they had been kept alive in a cryogenic nursery while they awaited implantation, which tragically never happened because of the defendants’ alleged negligence.
The opinion of the court, which was written by Justice James Mitchell, handles the case as a fairly straightforward statutory interpretation case. However, the court’s decision has generated considerable discussion in the United States and beyond for at least three reasons. First, the decision seems to pose an impediment for individuals and couples who seek fertility and reproductive services to have children. Second, the decision exposes to civil liability under the act those within the fertility industry who provide fertility services but fail to exercise appropriate care as to human embryos within their care. Third, the decision threatens research programs that desire a reliable supply of human embryos that can be used in research. For these and other reasons, the decision and its implications deserve careful consideration.
1. What is IVF, and what is the fertility industry?
Before turning to the court’s decision itself, we should consider the IVF procedure and the fertility industry. IVF is a procedure in which a woman’s egg is fertilized by a man’s sperm outside the woman’s body in a laboratory dish. After fertilization, embryos are implanted in the uterus of the intended carrier who may or may not be related to the embryos and may or may not be an intended parent. The sperm donor too may or may not be an intended parent. Physicians seeking to achieve pregnancy often implant multiple embryos that had not been eliminated by preimplantation genetic testing, hoping at least one will make it to term. Because multiple embryos are often transferred, there is a risk of a multiple pregnancy, and physicians will sometimes abort fetuses through selective reduction to minimize risks to the mother and the children. Embryos that are not transferred to the woman’s uterus are frozen and stored for later use, given to another individual or couple, donated for research, or destroyed.
The fertility industry provides a range of fertility services, including intrauterine insemination and IVF. It is a growing industry with a market size valued at over $5 billion in 2023. Despite its size and profitability, the fertility industry has operated in an environment of lax regulation, which has led some observers to view the industry in the United States as the “Wild West.” In explaining the reason for this, American bioethicist Arthur L. Caplan has noted that reproductive medicine is “unregulated because it touches on two, ‘third-rail’ issues”—it “touches on abortion and also the creation of embryos, which politicians run away from because too many people still disagree about the right to use reproductive technologies, particularly who should pay for them and how much.”[1] Nevertheless, examples of carelessness in this underregulated industry’s provision of services are not difficult to find. For instance, almost five years ago, an institutional provider in Ohio settled with more than 150 families after a freezer failed and caused the loss of 4,000 eggs and embryos,[2] and fifteen years ago, the multiple pregnancy of Nadya Suleman (commonly known the “Octomom”) captured national attention and shined a spotlight on lax IVF regulation and poor professional judgment.[3]
No comments have been added.